Clinical Trial Update: Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the pharmacokinetics, pharmacodynamics, efficacy, and safety of HRG2010 in Parkinson's disease patients with motor fluctuati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• HRG2010

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED